Executive Profile

Dayton Misfeldt Investment Partner, Bay City Capital LLC

Age	Total Calculated Compensation	This person is connected to 3 Board Members in 3 different organizations across 4 different industries. See Board Relationships
38	--

Background

Mr. Dayton Misfeldt serves as Investment Partner at Bay City Capital LLC. Mr. Misfeldt joined the Bay City Capital in May 2000. He focuses on biopharmaceutical investment opportunities and has been involved in a number of investments. Previously, he served as a Vice President at Roth Capital Partners, where he worked as a sell side Analyst focusing on the biopharmaceutical industry. He was also involved in raising funds for Roth's corporate finance clients and marketing ... Roth's capabilities to the investment community. Mr. Misfeldt served as a Project Manager at LifeSciences Economics, Inc. Mr. Misfeldt serves as a Member of the Board of Directors of Aciex Therapeutics Inc. and Sunesis Pharmaceuticals and participates as an Observer on the Boards of Directors of Metabolex, MAP Pharmaceuticals, and Presidio Pharmaceuticals. He served as a Board Observer at Oculex Pharmaceuticals. Mr. Misfeldt received a B.A. degree in Economics from the University of California, San Diego.

Corporate Headquarters 750 Battery Street San Francisco, California 94111 United States Phone: 415-676-3830 Fax: 415-837-0503 Board Members Memberships Director NextWave Pharmaceuticals, Inc. Director Aciex Therapeutics Inc. 2009-Present Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee Sunesis Pharmaceuticals, Inc. Education BA University of California Other Affiliations Sunesis Pharmaceuticals, Inc. University of California University of California - San Diego Bay City Capital, LLC, Advisory Arm Roth Capital Partners, LLC, Research Division NextWave Pharmaceuticals, Inc. Aciex Therapeutics Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.